Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TAFASITAMAB-CXIX Cause C-reactive protein increased? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of C-reactive protein increased have been filed in association with TAFASITAMAB-CXIX. This represents 0.8% of all adverse event reports for TAFASITAMAB-CXIX.

6
Reports of C-reactive protein increased with TAFASITAMAB-CXIX
0.8%
of all TAFASITAMAB-CXIX reports
0
Deaths
3
Hospitalizations

How Dangerous Is C-reactive protein increased From TAFASITAMAB-CXIX?

Of the 6 reports, 3 (50.0%) required hospitalization.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does TAFASITAMAB-CXIX Cause?

Disease progression (218) Lymphoma (158) Off label use (126) Death (53) Drug ineffective (39) Blood lactate dehydrogenase increased (34) Diffuse large b-cell lymphoma (32) Malignant neoplasm progression (30) Neutropenia (30) Polyneuropathy (29)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which TAFASITAMAB-CXIX Alternatives Have Lower C-reactive protein increased Risk?

TAFASITAMAB-CXIX vs TAFINLAR TAFASITAMAB-CXIX vs TAFLUPROST TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS TAFASITAMAB-CXIX vs TAHOR TAFASITAMAB-CXIX vs TALAZOPARIB

Related Pages

TAFASITAMAB-CXIX Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased TAFASITAMAB-CXIX Demographics